Hlongwa, K.N.; Mokoala, K.M.G.; Matsena-Zingoni, Z.; Vorster, M.; Sathekge, M.M.
The Use of 18F-FDG PET/CT Metabolic Parameters in Predicting Overall Survival in Patients Undergoing Restaging for Malignant Melanoma. Diagnostics 2022, 12, 595.
https://doi.org/10.3390/diagnostics12030595
AMA Style
Hlongwa KN, Mokoala KMG, Matsena-Zingoni Z, Vorster M, Sathekge MM.
The Use of 18F-FDG PET/CT Metabolic Parameters in Predicting Overall Survival in Patients Undergoing Restaging for Malignant Melanoma. Diagnostics. 2022; 12(3):595.
https://doi.org/10.3390/diagnostics12030595
Chicago/Turabian Style
Hlongwa, Khanyisile N., Kgomotso M. G. Mokoala, Zvifadzo Matsena-Zingoni, Mariza Vorster, and Mike M. Sathekge.
2022. "The Use of 18F-FDG PET/CT Metabolic Parameters in Predicting Overall Survival in Patients Undergoing Restaging for Malignant Melanoma" Diagnostics 12, no. 3: 595.
https://doi.org/10.3390/diagnostics12030595
APA Style
Hlongwa, K. N., Mokoala, K. M. G., Matsena-Zingoni, Z., Vorster, M., & Sathekge, M. M.
(2022). The Use of 18F-FDG PET/CT Metabolic Parameters in Predicting Overall Survival in Patients Undergoing Restaging for Malignant Melanoma. Diagnostics, 12(3), 595.
https://doi.org/10.3390/diagnostics12030595